Is procalcitonin a reliable marker of sepsis in critically ill septic patients undergoing continuous veno-venous hemodiafiltration with "high cut-off" membranes (HCO-CVVHDF)?

Clinical Chemistry and Laboratory Medicine

Volumn 51, Issue 11, 2013, Pages

  Caldini, Anna ^a   Chelazzi, Cosimo ^b   Terreni, Alessandro ^a   Biagioli, Tiziana ^a   Giannoni, Claudia ^b   Villa, Gianluca ^b   Messeri, Gianni ^a   De Gaudio, Angelo R ^b  

^a CAREGGI UNIVERSITY HOSPITAL   (Italy)

^b UNIVERSITY OF FLORENCE   (Italy)

Author keywords

acute kidney injury; C reactive protein; high cut off hemodiafiltration; procalcitonin; sepsis

Indexed keywords

BIOLOGICAL MARKER; C REACTIVE PROTEIN; INTERLEUKIN 6; PROCALCITONIN; TUMOR NECROSIS FACTOR ALPHA;

ACUTE KIDNEY FAILURE; CONTINUOUS HEMODIAFILTRATION; CRITICALLY ILL PATIENT; DIALYSIS MEMBRANE; DISEASE MARKER; HIGH CUT OFF MEMBRANE; HUMAN; LETTER; OBSERVATIONAL STUDY; PRIORITY JOURNAL; PROSPECTIVE STUDY; RELIABILITY; SEPSIS;

ACUTE KIDNEY INJURY; BIOLOGICAL MARKERS; C-REACTIVE PROTEIN; CALCITONIN; CRITICAL ILLNESS; HEMOFILTRATION; HUMANS; MEMBRANES, ARTIFICIAL; PROTEIN PRECURSORS; SEPSIS; VEINS;

EID: 84886688781     PISSN: 14346621     EISSN: 14374331     Source Type: Journal    
DOI: 10.1515/cclm-2013-0257     Document Type: Letter

References (10)

1. Kim DY, Lee YS, Ahn S, Chun YH, Lim KS. The usefulness of procalcitonin and C-reactive protein as early diagnostic markers of bacteremia in cancer patients with febrile neutropenia. Cancer Res Treat 2011;43:176-80
2. Riedel S. Procalcitonin and the role of biomarkers in the diagnosis and management of sepsis. Diagn Microbiol Infect Dis 2012;73:221-7
3. Schuetz P, Albrich W, Mueller B. Procalcitonin for diagnosis of infection and guide to antibiotic decisions: Past, present and future. BMC Med 2011;9:107-16
4. Povoa P. C-reactive protein: A valuable marker of sepsis. Intensive Care Med 2002;28:235-43
5. Miguel-Bayarri V, Casanoves-Laparra EB, Pallás-Beneyto L, Sancho-Chinesta S, Martín-Osorio LF, Tormo-Calandín C, et al. Prognostic value of the biomarkers procalcitonin, interleukin-6 and C-reactive protein in severe sepsis. Med Intensiva. 2012;36:556-62
6. Honoré PM, Matson Jr. Hemofiltration, adsorption, sieving and the challenge of sepsis therapy design. Crit Care 2002;6:394-6
7. Haase M, Bellomo R, Morgera S, Baldwin I, Boyce N. High cut-off point membranes in septic acute renal failure: A systematic review. Int J Artif Organs 2007;30:1031-41
8. Meisner M, Hüttemann E, Lohs T, Kasakov L, Reinhart K. Elimination of procalcitonin and plasma concentrations during continuous veno-venous haemodiafiltration in septic patients. Eur J Anaesthesiol 2000;17:665-71
9. Dahaba AA, Elawady GA, Rehak PH, List WF. Procalcitonin and proinflammatory cytokine clearance during continuous venovenous haemofiltration in septic patients. Anaesth Intensive Care 2002;30:269-74
10. Matera G, Quirino A, Giancotti A, Pulicari MC, Rametti L, Rodríguez ML, et al. Procalcitonin neutralizes bacterial LPS and reduces LPS-induced cytokine release in human peripheral blood mononuclear cells. BMC Microbiol 2012;12:68-77